![]() |
|
|
3 Department of Health Science, University of Jaén, 23071 Jaén, Spain; 4 Department of Human Anatomy and Embryology, University of Granada, 18012 Granada, Spain; 5 Department of Cell Biology, University of Granada, 18071 Granada, Spain; 6 Department of Health Sciences, University of Almería, 04120 Almería, Spain; and 7 Biopathology and Regenerative Medicine Institute, 18100 Granada, Spain
* To whom correspondence should be addressed. E-mail: aranega{at}ugr.es.
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Because of the existence of the de novo synthesis pathway, NT are not considered essential nutrients nor have there been reports of diseases related to a deficit in the exogenous contribution of NT (5,6). Nevertheless, numerous studies have indicated that exogenous NT are important for normal gastrointestinal development and maintenance (7–11), leading to their description as semiessential or conditionally essential nutrients for tissues with a rapid cell turnover rate and limited capacity for de novo synthesis (6,12).
A small amount of NT is absorbed through cell membranes and it is mainly NS, which appear after release of phosphate groups, that cross into cells (13–15). This process occurs through an active sodium cotransport mechanism, localized in the apical cellular membrane in intestinal epithelium, and through passive transport by facilitated diffusion, localized in basolateral membrane (16,17). The differential localization of transporters supports the hypothesis that coordinated action permits the trans-epithelial transport of NS (18).
The objective of this study was to evaluate effects of exogenous NS, the best-absorbed chemical form of NT, on the intestinal epithelium, to clarify, at the cellular level, the effects described in vivo. For this purpose, we studied the intracellular incorporation capacity of exogenous NS and their influence on the growth, morphology, cell cycle phase distribution, and cell viability of rat intestinal epithelial cell line 6 (IEC-6). These cells were isolated from rat jejunum (19). It is important to consider that these cells come from intestinal crypts, where the effective concentrations of NS may not be the same as that in the luminal epithelium.
| Materials and Methods |
|---|
|
|
|---|
Nucleoside treatment and experimental groups. NS frequently found in plasma were used in the assays. To differentiate between DNA and RNA, 2 mixtures were used that differed solely in the presence of uridine or thymidine, respectively (20). One group was treated with an NS mixture composed of thymidine, cytidine, guanosine, and inosine (T-CGI). Another group was treated with an NS mixture composed of uridine, cytidine, guanosine, and inosine (U-CGI). A Control group received no NS supplementation. Unless otherwise stated, the final concentration of each NS in the mixtures was 100 µmol/L, and the medium was changed every 12 h in all experiments. All NS were purchased from Sigma Chemical. Starting cell density for all experiments was 5 x 103 cells/cm2 (low density) and, after the conclusion of the respective assays, in no case was a confluence >70% reached.
Tritium assays. Uridine and guanosine were selected for studies of NS incorporation, intracellular distribution, and differences between pyrimidine and purine chemical groups in IEC-6 cells. The following culture media were prepared: T-CGI/tritium, composed of DMEM supplemented with thymidine, cytidine, and inosine (100 µmol/L each) plus 200 mCi/L tritiated guanosine (Moravek Biochemicals) brought to 100 µmol/L with nontritiated guanosine; U-CGI/tritium, similar to the previous medium but with guanosine, cytidine, and inosine (100 µmol/L each) plus 200 mCi/L tritiated uridine (Moravek Biochemicals) brought to 100 µmol/L with nontritiated uridine; and control medium containing no NS or tritium.
Nucleoside clearance from culture medium. Cells seeded in Transwells (Corning) were incubated with T-CGI/tritium, U-CGI/tritium, or control culture medium. After incubation in the apical chamber for 0, 0.5, 1, 2, 3, 4, 6, 8, 10, or 12 h, the medium was collected, diluted 1:3000 (v:v) with scintillation support medium (Ecolumen, ICN Biomedicals), and total radioactive amount was then determined by liquid scintillation counting (Beckman, LS6000).
Intracellular nucleoside incorporation by electron microscopy autoradiography. Monolayers from the above Transwell cultures at 0.5, 1, or 4 h were washed 3 times in cold PBS at 4°C, prefixed for 60 min at 4°C with 2.5% glutaraldehyde in cacodylate buffer (0.1 mol/L, pH 7.4), fixed with 1% osmium tetroxide in cacodylate buffer for 60 min at 4°C (Merck), dehydrated in ethanol, and embedded in Embed 812 (Electron Microscopy Science). Ultrathin sections (90–120 nm) were collected in a Formvar-coated copper grid, double-stained with 5% uranyl acetate for 15 min and 6% lead citrate for 1 min, air dried, and coated with a 5 nm-thick carbon layer (21).
Next, the grids were coated with Ilford L4 nuclear emulsion (Ilford Imaging) by the "wire loop method" (22) and kept in the dark for 80 d at 4°C. Subsequently, grids were developed with phenidone-ascorbic acid mixture for 2 min, washed with distilled water, and fixed with 30% sodium thiosulfate for 5 min. The developing mixture was composed of 1.5% ascorbic acid, 0.25% photographic grade phenidone, 0.6% potassium bromide, 1.3% potassium carbonate, and 6% potassium thiocyanate (Sigma Chemical).
Grids were studied under transmission electron microscope (Zeiss 902, Carl Zeiss). Images were scanned, and silver grains were counted. Three variables related to radioactive density were determined, calculating the incorporation index (marks per area unit x 10.000, with each real µm2 on electron micrographs equivalent to 2997.4 units of digital area) for the whole cell (total incorporation index, TII), the nucleus (nuclear incorporation index, NII), and the cytoplasm (cytoplasmic incorporation index, CII).
Proliferation assays. Cells were incubated with T-CGI, U-CGI, or control culture media. On d 1–7, four samples per treatment were fixed with 10% cold trichloroacetic and stained with 0.4% B sulforhodamine in 1% acetic acid, and the dye that was bound to cells was subsequently resuspended with 10 mmol/L Tris-base buffer (pH 10.5). Optical density was then determined using a Titertek multiscan colorimeter at 492 nm (23).
Effects of increasing concentrations of the T-CGI and U-CGI NS mixtures were characterized by seeding cells and exposing them to concentrations of 10, 25, 50, 75, or 100 µmol/L. On d 7, cells were fixed and processed for B sulforhodamine staining, as described above.
Protein content. To verify differences in proliferation among experimental groups, total protein amount was measured after 7 d of incubation. Cell layers were harvested with PBS-EDTA (0.02%) solution and washed with PBS, and pellets were resuspended in sample buffer composed of 62.5 mmol/L Tris-HCl, pH 6.8, 10% glycerol, 2% sodium dodecyl sulfate (Sigma Chemical), 5% 2-mercaptoethanol, 0.5% bromophenol blue, and 100 mmol/L dithiothreitol (Bio-Rad). Then, samples were homogenized, boiled, and centrifuged at 14000 x g for 10 min. Total protein amount of the supernatant was measured by the Lowry method (24).
Morphology. The study of cell morphology was carried out using a Nikon TM Phase Contrast-2 ELWD inverted optical microscope.
Cell viability and apoptotic assays. Effects of NS mixtures on cell viability, necrosis, and apoptosis were evaluated by monitoring the binding of FITC-labeled annexin V and the entry of propidium iodide (PI) into cell nucleus by means of the TACS Annexin V-FITC apoptosis detection kit (R & D Systems). Cells were incubated with or without NS mixtures. After 7 d of culture, cells were processed according to manufacturer's instructions and analyzed in a Vantage flow cytometer (Becton Dickinson).
Cell cycle phase distribution analysis. Cells were incubated with T-CGI, U-CGI, or control culture media. After 7 d of culture, the medium was aspirated and cells were harvested with a PBS-EDTA (0.02%) solution, washed twice with sample buffer (1 g/L glucose in PBS without Ca2+ or Mg2+), and fixed overnight in 70% cold ethanol. Next, cells were pelleted, washed once with sample buffer, and resuspended in 50 mg/L PI staining solution for 30 min in the dark. Samples were then analyzed using a Vantage flow cytometer (Becton Dickinson) with CellFIT cell cycle analysis software.
Statistical analysis. All values are means ± SD. Statistical analysis was carried out using Statgraphics, version 5.1 (Statistical Graphics, 2000). The analyses performed were simple regression, 1- or 2-way ANOVA, and multiple mean comparisons using Fisher's least significant differences test. Significant differences were determined at P < 0.05. Graphics of the collected data were made using Microsoft Office Excel 2003 software (Microsoft Corporation).
| Results |
|---|
|
|
|---|
Intracellular nucleoside incorporation by electron microscopy autoradiography. On the electron micrographs, marks were observed in specific organelles (e.g., rough endoplasmic reticulum and mitochondrion) independent of incubation time (Fig. 1). Large amounts of silver grains were frequently observed in heterochromatic regions and nucleoli. A predominance of marks in the nucleus was clearly noted. However, an ordered and defined route of NS incorporation through intracellular compartments was not observed.
|
|
|
Cultivation of cells at increasing concentrations for 7 d showed an increased growth in the T-CGI group than in the other 2 groups from a concentration of 25 µmol/L, whereas growth in the U-CGI group did not differ from that of the control group until a concentration of 75 µmol/L was reached (Fig. 4).
|
Cell viability and apoptotic assays. Similar values were obtained among the control (93.34% of viable cells, 4.52% of necrotic cells, and 2.15% of apoptotic cells), T-CGI (94.56, 4.17, and 1.27%, respectively) and U-CGI (93.29, 4.76, and 1.95%, respectively) groups, with no significant differences in respective percentages among them (Supplemental Fig. 1).
Cell-cycle phase distribution analysis. In the flow cytometry study (Supplemental Fig. 2), control cultures contained 60.73% of cells in G0/G1, 15.55% in G2/M and 23.73% in S-phase; T-CGI group showed a reduction in S-phase (9.06%) and a corresponding accumulation in G0/G1 (69.38%) and G2/M (21.56%); and U-CGI group showed an intermediate picture, with a significant reduction vs. controls in S (20.10%) that was solely due to an increase in G0/G1 (66.69%), with no significant difference in the G2/M-phase percentage (13.22%).
| Discussion |
|---|
|
|
|---|
Nucleoside clearance. Observations of NS uptake in IEC-6 cells showed that both types of molecules, purine (guanosine) and pyrimidine (uridine), were rapidly cleared from culture mediums. The absorption profile of these NS did not differ in the present study. However, in previous studies with cultures of isolated adult rat hepatocytes, guanosine disappeared from the culture mediums of T-CGI and U-CGI at 3 h, whereas there was a gradually reduced concentration of uridine until its disappearance at 24 h (27).
The absorption capacity is lower in fetal rat hepatocytes than in adult rat hepatocytes or IEC-6 cells. In the former, Sáez-Lara et al. (20) found that 40–50% of guanosine and 70% of uridine remained in culture medium after 48 h of incubation. These authors also reported the interesting result that NS uptake was minimally influenced by the mixture used (T-CGI or U-CGI).
Intracellular nucleoside incorporation. Absorbed NS augments the intracellular nucleotide pool (27,28) that can be used for nucleic acid synthesis (29,30). Indeed, the preferential localization of radioactive grains in the cell nucleus, as found in the present study, suggests that the IEC-6 cells mainly used the NS for this purpose, at least during the incubation period assayed.
An analysis of the distribution of radioactive marks showed some differences between guanosine and uridine. At 4 h, the TII index was higher for guanosine than for uridine, although this difference was not observed in the absorption curve, which may be due to a differential use of exogenous NS by IEC-6 cells.
In 1994, Sanderson et al. (31) studied differentiated human colon adenocarcinoma cells (Caco-2) and observed transepithelial transport from the apical to the basolateral membrane and vice-versa; the former was faster and showed greater capacity than the latter, and guanosine was one of the most rapidly transported NS. Therefore, there may have been variations in levels of transepithelial transport in our assays, leaving differentially tritiated NS in the lower compartment of transwells, which may explain the differences found between guanosine and uridine.
Proliferation. Ohyanagi et al. (32) incubated primary cultures of hepatocytes with inosine, GMP, cytidine, uridine, and thymidine. They found that NS produced an inhibition of DNA or RNA synthesis when the concentration was >1 mmol/L, and the optimal concentration of uridine used alone was 23–230 µmol/L.
The total NS concentration of mixtures was 400 µmol/L (T-CGI or U-CGI) in the present study. These combinations and concentrations of NS were recently used by other authors in hepatocytes (20,27,33) and were considered closer to physiological values because they were <1 mmol/L and no toxicity was found in a 24-h viability assay (20).
Ohyanagi et al. (32) did not find that uridine concentration <230 µmol/L reduced proliferation after examining the first 24 h of incubation, whereas significant differences in proliferation emerged after d 6 of culture in the present study. Moreover, uridine was present in body fluids at concentrations <75 µmol/L (34), which was the lowest concentration that produced inhibition in cultures of the present study. The above data suggest that uridine levels >75 µmol/L should not be considered physiological values in IEC-6 cells.
In adult rat hepatocyte cultures, NS mixtures did not modify cell proliferation or viability (27). However, an incubation period of only 24 h was studied, and effects on enterocytes were observed after longer incubation in the present study. In fetal rat hepatocytes, however, both mixtures produced an increase of proliferation within 24 h, which was more marked for U-CGI (20).
NT in human milk (AMP, CMP, GMP, IMP, and UMP) did not affect the proliferation rate of Caco-2 tumor cells under normal nutritional conditions, but they increased the growth rate in cells when nutritional stress conditions were simulated by glutamine removal. IEC-6 cells were affected under both nutritional conditions and showed an increase in cell proliferation (29,35).
In the present assays, significant differences in the proliferation of IEC-6 cells were found, but not due to a glutamine restriction. Our study differs importantly from others insofar as others have used NT as the chemical form of purines and pyrimidines, whereas we used NS, which are better absorbed (13–15). In this context, Holen et al. (36) found that proliferation rate did not differ when IEC-6 cells were incubated with complex mixtures containing DNA sodium salt extracted from fish spawn or yeast RNA, except under nutritional stress conditions without glutamine and with a 50% reduction in fetal bovine serum. In our opinion, there is lower cellular bioavailability of NS from these complex molecules than from mixtures of isolated NS, because it depends on extracellular degradation of DNA and RNA by different catabolic enzymes (37), some of which are related to the differentiation status of cells (38).
We initially speculated that the inhibition of proliferation by the U-CGI mixture in our assays might be due either to a possible toxicity of the mixture, which would affect cell viability, or to its stimulation of cell differentiation by cell cycle blockade, with cells kept in nonproliferative state and acquiring differentiated characteristics.
Cell viability and apoptosis. Epithelial homeostasis is maintained by the balance between cell division and apoptosis (39). Our IEC-6 cells showed similar apoptosis and necrosis levels to those reported by other authors in control cultures of IEC-6 cells (40,41). Moreover, because these data did not differ among experimental groups, the differences in proliferation profile cannot be explained by variations in cellular viability, necrosis, or apoptosis.
Holen et al. (36) also found an inhibition of Caco-2 cell proliferation under optimal nutritional conditions after treatment with DNA sodium salt extracted from fish spawn and yeast RNA. They did not consider the mixture to be toxic, because growth was promoted under conditions of nutritional stress (see above). They ascribed the antiproliferative effect to the stimulation of P2Y receptors by exogenous NT, inducing apoptosis and cell growth inhibition (42).
Cell cycle phase distribution. NS, especially the T-CGI mixture, reduced the percentage of cells in S-phase. This appears to be due to a reduction by the NS in the time needed for cells to complete S-phase, thereby increasing G2/M phase accumulation, as observed in the T-CGI group. However, the U-CGI group showed no difference with controls in G2/M, and there was a lower proliferation rate in both groups. On the other hand, the NS produced an increased percentage of cells in G0-G1 phase, considered necessary to begin the differentiation process (43). Cell cycle phase distribution in the U-CGI group showed intermediate behavior between those in the T-CGI and control groups. However, it was not possible to detect variations that explained the differences in antiproliferative response.
In summary, exogenous NS are molecules that are well-absorbed by intestinal epithelial cells and that can promote or inhibit their proliferation according to the mixture used. Our results also indicate that >75 µmol/L of uridine should not be considered a physiological value for IEC-6, and lower NS concentrations should therefore be applied in future assays. Finally, the antiproliferative effect of the U-CGI mixture was not associated with a reduction in cell viability. Further studies are warranted on the effects exerted by T-CGI and U-CGI mixtures on the differentiation of IEC-6 cells.
| FOOTNOTES |
|---|
2 Supplemental Figures 1 and 2 are available with the online posting of this paper at jn.nutrition.org. ![]()
8 Abbreviations used: Caco-2, human colon adenocarcinoma cell; CII, cytoplasmic incorporation index; IEC-6, rat intestinal epithelial cell line 6; NII, nuclear incorporation index; NS, nucleoside; NT, nucleotide; PI, propidium iodide; T-CGI, IEC-6 cells treated with thymidine, cytidine, guanosine, and inosine; TII, total incorporation index; U-CGI, IEC-6 cells treated with uridine, cytidine, guanosine, and inosine. ![]()
Manuscript received 9 November 2006. Initial review completed 7 December 2006. Revision accepted 3 January 2007.
| LITERATURE CITED |
|---|
|
|
|---|
1. Rudolph FB. The biochemistry and physiology of nucleotides. J Nutr. 1994;124:124S–7S.
2. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2001;414:916–20.[Medline]
3. Fishman P, Bar-Yehuda S, Madi L, Cohn I. A3 adenosine receptor as a target for cancer therapy. Anticancer Drugs. 2002;13:437–43.[Medline]
4. Carver JD, Allan Walker W. The role of nucleotides in human nutrition. J Nutr Biochem. 1995;6:58–72.
5. Cosgrove M. Perinatal and infant nutrition. Nucleotides. Nutrition. 1998;14:748–51.
6. Sanchez-Pozo A, Gil A. Nucleotides as semiessential nutritional components. Br J Nutr. 2002;87: Suppl 1:S135–137.[Medline]
7. Carver JD. Dietary nucleotides: cellular immune, intestinal and hepatic system effects. J Nutr. 1994;124:144S–8S.
8. Carver JD. Advances in nutritional modifications of infant formulas. Am J Clin Nutr. 2003;77:1550S–1554.[Medline]
9. Ortega MA, Nunez MC, Gil A, Sanchez-Pozo A. Dietary nucleotides accelerate intestinal recovery after food deprivation in old rats. J Nutr. 1995;125:1413–8.
10. Tsujinaka T, Kishibuchi M, Iijima S, Yano M, Monden M. Nucleotides and intestine. JPEN J Parenter Enteral Nutr. 1999;23:S74–77.
11. Uauy R, Quan R, Gil A. Role of nucleotides in intestinal development and repair: implications for infant nutrition. J Nutr. 1994;124:1436S–41S.
12. Van Buren CT, Rudolph F. Dietary nucleotides: a conditional requirement. Nutrition. 1997;13:470–2.[Medline]
13. Carver JD. Dietary nucleotides: effects on the immune and gastrointestinal systems. Acta Paediatr Suppl. 1999;88:83–8.[Medline]
14. Sonoda T, Tatibana M. Metabolic fate of pyrimidines and purines in dietary nucleic acids ingested by mice. Biochim Biophys Acta. 1978;521:55–66.[Medline]
15. Ho CY, Miller KV, Savaiano DA, Crane RT, Ericson KA, Clifford AJ. Absorption and metabolism of orally administered purines in fed and fasted rats. J Nutr. 1979;109:1377–82.
16. Cass CE, Young JD, Baldwin SA. Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem Cell Biol. 1998;76:761–70.[Medline]
17. Baldwin SA, Mackey JR, Cass CE, Young JD. Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today. 1999;5:216–24.[Medline]
18. Casado FJ, Lostao MP, Aymerich I, Larrayoz IM, Duflot S, Rodriguez-Mulero S, Pastor-Anglada M. Nucleoside transporters in absorptive epithelia. J Physiol Biochem. 2002;58:207–16.[Medline]
19. Wood SR, Zhao Q, Smith LH, Daniels CK. Altered morphology in cultured rat intestinal epithelial IEC-6 cells is associated with alkaline phosphatase expression. Tissue Cell. 2003;35:47–58.[Medline]
20. Saez-Lara MJ, Manzano M, Angulo AJ, Suarez A, Torres MI, Gomez-Llorente C, Gil A, Fontana L. Exogenous nucleosides stimulate proliferation of fetal rat hepatocytes. J Nutr. 2004;134:1309–13.
21. Hernández-Yago J, Hernández JM. Autorradiografía de alta resolución. In: Renau J, Megías L, editors. Manual de técnicas de microscopía electrónica. Granada: Editorial de la Universidad de Granada; 1998. p. 369–391.
22. Nagata T. Techniques and application of electron microscopic radioautography. J Electron Microsc (Tokyo). 1996;45:258–74.
23. Papazisis KT, Geromichalos GD, Dimitriadis KA, Kortsaris AH. Optimization of the sulforhodamine B colorimetric assay. J Immunol Methods. 1997;208:151–8.[Medline]
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–75.
25. Gil A. Modulation of the immune response mediated by dietary nucleotides. Eur J Clin Nutr. 2002;56: Suppl 3:S1–4.
26. Grimble RF. Nutritional modulation of immune function. Proc Nutr Soc. 2001;60:389–97.[Medline]
27. Arnaud A, Fontana L, Angulo AJ, Gil A, Lopez-Pedrosa JM. Exogenous nucleosides alter the intracellular nucleotide pool in hepatic cell cultures. Implications in cell proliferation and function. Clin Nutr. 2003;22:391–9.[Medline]
28. He Y, Chu SH, Walker WA. Nucleotide supplements alter proliferation and differentiation of cultured human (Caco-2) and rat (IEC-6) intestinal epithelial cells. J Nutr. 1993;123:1017–27.
29. Bissonnette R. The de novo and salvage pathways for the synthesis of pyrimidine residues of RNA predominate in different locations within the mouse duodenal epithelium. Cell Tissue Res. 1992;267:131–7.[Medline]
30. Nagata T. Radioautographology: the proposal of a new concept. Braz J Med Biol Res. 1998;31:978–1018.[Medline]
31. Sanderson IR, He Y. Nucleotide uptake and metabolism by intestinal epithelial cells. J Nutr. 1994;124:131S–7S.
32. Ohyanagi H, Nishimatsu S, Kanbara Y, Usami M, Saitoh Y. Effects of nucleosides and a nucleotide on DNA and RNA syntheses by the salvage and de novo pathway in primary monolayer cultures of hepatocytes and hepatoma cells. JPEN J Parenter Enteral Nutr. 1989;13:51–8.
33. Arnaud A, Fontana L, Saez-Lara MJ, Gil A, Lopez-Pedrosa JM. Exogenous nucleosides modulate the expression of rat liver extracellular matrix genes in single cultures of primary hepatocytes and a liver stellate cell line and in their co-culture. Clin Nutr. 2004;23:43–51.[Medline]
34. Moyer JD, Oliver JT, Handschumacher RE. Salvage of circulating pyrimidine nucleosides in the rat. Cancer Res. 1981;41:3010–7.
35. Sato N, Nakano T, Kawakami H, Idota T. In vitro and in vivo effects of exogenous nucleotides on the proliferation and maturation of intestinal epithelial cells. J Nutr Sci Vitaminol (Tokyo). 1999;45:107–18.[Medline]
36. Holen E, Roland J. Dietary nucleotides and intestinal cell lines: I. modulation of growth. Nutr Res. 2004;24:197–207.
37. Quan R, Barness LA. Do infants need nucleotide supplemented formula for optimal nutrition? J Pediatr Gastroenterol Nutr. 1990;11:429–34.[Medline]
38. Sato N, Kawakami H, Idota A. Nucleotide and nucleoside supplementation may morphologically promote the differentiation of human caco-2 cells. J Nutr Sci Vitaminol (Tokyo). 2000;46:175–9.[Medline]
39. Potten C, Wilson J. An in vivo system to study apoptosis: the small intestine. In: Apoptosis. The life and death of cells. Cambridge: Cambridge University Press; 2004. p. 136–183.
40. Neopikhanov V, Samali A, Wreiber K, Engstrand L, Uribe A. 40- to 100-kD protein(s) of Helicobacter pylori stimulate DNA synthesis in epithelial cell lines without affecting apoptosis. Digestion. 2000;61:22–9.[Medline]
41. Zhang HM, Rao JN, Guo X, Liu L, Zou T, Turner DJ, Wang JY. Akt kinase activation blocks apoptosis in intestinal epithelial cells by inhibiting caspase-3 after polyamine depletion. J Biol Chem. 2004;279:22539–47.
42. Hopfner M, Maaser K, Barthel B, von Lampe B, Hanski C, Riecken EO, Zeitz M, Scherubl H. Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells: involvement of intracellular calcium and cyclic adenosine monophosphate. Int J Colorectal Dis. 2001;16:154–66.[Medline]
43. Fajkus J, Borsky M, Kunicka Z, Kovarikova M, Dvorakova D, Hofmanova J, Kozubik A. Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells. Anticancer Res. 2003;23:1605–12.[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||